- Home
- HRTX vs CEE Comparison
HRTX vs CEE Comparison
Compare HRTX & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.79
Company Overview
Basic Information| Metric | HRTX | CEE |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.8M | 128.1M |
| IPO Year | 2007 | 1994 |
Fundamental Metrics
Financial Performance| Metric | HRTX | CEE |
|---|---|---|
| Price | $0.79 | $17.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 23.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $15.28 | N/A |
| Revenue Next Year | $20.29 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.75 | $11.20 |
| 52 Week High | $2.61 | $19.98 |
Technical Indicators
Market Signals| Indicator | HRTX | CEE |
|---|---|---|
| Relative Strength Index (RSI) | 30.25 | 38.36 |
| Support Level | N/A | $16.97 |
| Resistance Level | $1.41 | $18.35 |
| Average True Range (ATR) | 0.06 | 0.69 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 13.10 | 12.10 |
Price Performance
Historical Comparison HRTX
CEE
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.